Retinitis pigmentosa and allied conditions today: a paradigm of translational research.
Autores de IIS La Fe
Abstract
Monogenic human retinal dystrophies are a group of disorders characterized by progressive loss of photoreceptor cells leading to visual handicap. Retinitis pigmentosa is a type of retinal dystrophy where degeneration of rod photoreceptors occurs at the early stages. At present, there are no available effective therapies to maintain or improve vision in patients affected with retinitis pigmentosa, but post-genomic studies are allowing the development of potential therapeutic approaches. This review summarizes current knowledge on genes that have been identified to be responsible for retinitis pigmentosa, the involvement of these genes in the different forms of the disorder, the role of the proteins encoded by these genes in retinal function, the utility of genotyping, and current efforts to develop novel therapies.
Datos de la publicación
- ISSN/ISSNe:
- 1756-994X, 1756-994X
- Tipo:
- Article
- Páginas:
- 34-34
- DOI:
- 10.1186/gm155
- PubMed:
- 20519033
- Factor de Impacto:
- 1,720 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Genome Medicine BioMed Central
Citas Recibidas en Web of Science: 103
Documentos
- No hay documentos
Filiaciones
Cita
AYUSO C,MILLAN JM. Retinitis pigmentosa and allied conditions today: a paradigm of translational research. Genome Med. 2010. 2. (5):p. 34-34.
Portal de investigación